28549770|t|Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor Derived Constitutional Abnormality
28549770|a|Allogeneic hematopoietic cell transplantation (HCT) is an important treatment for many severe hematological disorders. However HCT can be associated with significant complications including organ toxicity, graft -versus-host disease and relapse. One other serious but rare complication is the transmission of hematologic and non- hematologic diseases from the donor to the recipient. With older donors, the risk of an abnormality in the donor may be higher. Here we describe the transmission of an inversion 3 constitutional cytogenetic abnormality from an unrelated donor to a recipient and review the clinical implications of the discovery of donor - derived constitutional cytogenetic abnormalities.
28549770	0	11	Inversion 3	T049	C0021943
28549770	12	35	Cytogenetic Abnormality	T033	C0262496
28549770	42	52	Allogeneic	T080	C1515895
28549770	53	71	Hematopoietic Cell	T025	C2323499
28549770	72	82	Transplant	T033	C3841811
28549770	83	92	Recipient	T098	C1709854
28549770	93	107	Representative	T169	C1522602
28549770	113	118	Donor	T098	C0013018
28549770	119	126	Derived	T080	C1441547
28549770	127	153	Constitutional Abnormality	T033	C0262496
28549770	154	199	Allogeneic hematopoietic cell transplantation	T061	C1705576
28549770	200	205	(HCT)	T061	C1705576
28549770	212	221	important	T080	C3898777
28549770	222	231	treatment	T061	C0087111
28549770	241	247	severe	T080	C0205082
28549770	248	271	hematological disorders	T047	C0018939
28549770	281	284	HCT	T061	C1705576
28549770	292	307	associated with	T080	C0332281
28549770	308	319	significant	T078	C0750502
28549770	320	333	complications	T046	C0009566
28549770	334	343	including	T169	C0332257
28549770	344	349	organ	T023	C0178784
28549770	350	358	toxicity	T037	C0600688
28549770	360	386	graft -versus-host disease	T047	C0018133
28549770	391	398	relapse	T067	C0035020
28549770	410	417	serious	T080	C0205404
28549770	422	426	rare	T080	C0522498
28549770	427	439	complication	T046	C0009566
28549770	447	459	transmission	T070	C1521797
28549770	463	474	hematologic	T047	C0018939
28549770	479	504	non- hematologic diseases	T047	C0012634
28549770	514	519	donor	T098	C0013018
28549770	527	536	recipient	T098	C1709854
28549770	543	548	older	T098	C0001792
28549770	549	555	donors	T098	C0013018
28549770	561	565	risk	T078	C0035647
28549770	572	583	abnormality	T033	C0262496
28549770	591	596	donor	T098	C0013018
28549770	604	610	higher	T080	C0205250
28549770	620	628	describe	T058	C0700287
28549770	633	645	transmission	T070	C1521797
28549770	652	663	inversion 3	T049	C0021943
28549770	664	702	constitutional cytogenetic abnormality	T033	C0262496
28549770	711	720	unrelated	T033	C0445356
28549770	721	726	donor	T098	C0013018
28549770	732	741	recipient	T098	C1709854
28549770	746	752	review	T078	C1552617
28549770	757	765	clinical	T080	C0205210
28549770	766	778	implications	T078	C1705535
28549770	786	795	discovery	T052	C1880355
28549770	799	804	donor	T098	C0013018
28549770	807	814	derived	T080	C1441547
28549770	815	855	constitutional cytogenetic abnormalities	T033	C0262496